Her2/neu testing in gastric cancer: evaluating the risk of sampling errors

By Warneke V. S.   Behrens H.-M.   Bger C.   Becker T.   Lordick F.   Ebert M. P. A.   Rcken C.  

Annals of Oncology, Vol. 24, Iss. 3, 2013-03 ,pp. : 725-733

Oxford University Press

Access to resources Recommend Favorite

Testing to Define the Target Her-2/neu

By Menard Sylvie  

Breast Cancer Research and Treatment, Vol. 81, Iss. 1, 2003-01 ,pp. : 63-66

Springer Publishing Company

Access to resources Recommend Favorite

Cost-effectiveness of HER2 testing and trastuzumab therapy for metastatic breast cancer

By Lidgren Mathias   Wilking Nils   Jonsson Bengt   Rehnberg Clas  

Acta Oncologica, Vol. 47, Iss. 6, 2008-08 ,pp. : 1018-1028

Informa Healthcare

Access to resources Recommend Favorite

Evaluation of HER-2/ NEU Protein Expression in Breast Cancer by Immunohistochemistry: An Interlaboratory Study Assessing the Reproducibility of HER-2/ NEU Testing

By Gancberg D.  

Breast Cancer Research and Treatment, Vol. 74, Iss. 2, 2002-07 ,pp. : 113-120

Springer Publishing Company

Access to resources Recommend Favorite

Consensus of the Spanish Society of Medical Oncology (SEOM) and Spanish Society of Pathology (SEAP) for HER2 testing in gastric carcinoma

By Gómez-Martín Carlos   Concha Ángel   Corominas José   García-Caballero Tomás   García-García Elena   Iglesias Mar   López José   Ramón y Cajal Santiago   Rojo Federico   Palacios José   Vera-Sempere Francisco   Aranda Enrique   Colomer Ramon   García-Alfonso Pilar   Garrido Pilar   Rivera Fernando   López-Ríos Fernando  

Clinical and Translational Oncology, Vol. 13, Iss. 9, 2011-09 ,pp. : 636-651

Springer Publishing Company

Access to resources Recommend Favorite